Suppr超能文献

口服对乙酰氨基酚预处理减少丙泊酚注射痛:一项随机安慰剂对照试验。

Premedication with oral paracetamol for reduction of propofol injection pain: a randomized placebo-controlled trial.

机构信息

Department of Anesthesiology, Faculty of Medicine, Prince of Songkla University, Hatyai, Songkhla, 90110, Thailand.

出版信息

BMC Anesthesiol. 2019 Jun 11;19(1):100. doi: 10.1186/s12871-019-0758-y.

Abstract

BACKGROUND

To compare the effect of premedication with 2 different doses of oral paracetamol to prevent pain at propofol intravenous injection.

METHODS

We conducted a double-blind randomized controlled trial in which patients scheduled for induction of general anesthesia with intravenous propofol received either a placebo, 500 mg or 1000 mg of oral paracetamol (P500 and P1000, respectively) 1 h prior to induction. Two mg/kg of propofol was injected at a rate of 600 ml/hr. After 1/4 of the full dose had been injected, the syringe pump was paused, and patients were asked to rate pain at the injection site using a verbal numerical rating score (VNRS) from 0 to 10.

RESULTS

Three hundred and twenty-four patients were included. Pain intensity was lower in both P500 and P1000 groups (median VNRS [interquartile range] = 2 [0-3] and 4 [2-5], respectively) than in the placebo group (8 [7-10]; P < 0.001). The rate of pain was lower in the P1000 group (70.4%) than in both the P500 and the placebo group (86.1 and 99.1%, respectively; P < 0.001). The respective rates of mild (VNRS 1-3), moderate (VNRS 4-6) and severe pain (VNRS 7-10) were 47.2, 23.2 and 0% in the P1000 group, 28.7, 50 and 7.4% in the P500 group, and 0, 22.2 and 76.9% in the placebo group (P < 0.001* for between group comparisons). Tolerance was similar in the 3 groups.

CONCLUSIONS

A premedication with oral paracetamol can dose-dependently reduce pain at propofol intravenous injection. To avoid this common uncomfortable concern for the patients, this well-tolerated, available and cheap treatment appears as an option to be implemented in the current practice.

TRIAL REGISTRATION

TCTR20150224002 . Prospectively registered on 24 February 2015.

摘要

背景

比较两种不同剂量的口服扑热息痛预防异丙酚静脉注射疼痛的效果。

方法

我们进行了一项双盲随机对照试验,纳入了计划接受异丙酚静脉诱导全身麻醉的患者,他们在诱导前 1 小时分别给予安慰剂、500mg 或 1000mg 口服扑热息痛(分别为 P500 和 P1000)。以 600ml/hr 的速度注射 2mg/kg 异丙酚。当注射了四分之一的全剂量后,暂停注射器泵,让患者使用从 0 到 10 的数字评分量表(VNRS)来评价注射部位的疼痛程度。

结果

共纳入 324 名患者。与安慰剂组相比,P500 组(中位数 VNRS [四分位数间距] = 2 [0-3])和 P1000 组(4 [2-5])的疼痛强度均较低(P < 0.001)。P1000 组的疼痛发生率(70.4%)低于 P500 组(86.1%)和安慰剂组(99.1%)(P < 0.001)。P1000 组的轻度(VNRS 1-3)、中度(VNRS 4-6)和重度疼痛(VNRS 7-10)发生率分别为 47.2%、23.2%和 0%,P500 组分别为 28.7%、50%和 7.4%,安慰剂组分别为 0%、22.2%和 76.9%(P < 0.001)*。三组间的耐受性相似。

结论

口服扑热息痛预处理可剂量依赖性地减轻异丙酚静脉注射疼痛。为避免这种常见的不适,这种耐受良好、可用且廉价的治疗方法似乎是一种可供选择的方案,可在当前的实践中实施。

试验注册

TCTR20150224002 。于 2015 年 2 月 24 日前瞻性注册。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a8f3/6560875/a16422eb9a43/12871_2019_758_Fig1_HTML.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验